|
SENP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.39119999995352E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20479999999412E-05 |
| Normal-vs-Stage2 |
1.475650E-01 |
| Normal-vs-Stage3 |
1.724210E-01 |
| Normal-vs-Stage4 |
7.132400E-01 |
| Stage1-vs-Stage2 |
5.326800E-01 |
| Stage1-vs-Stage3 |
2.993600E-01 |
| Stage1-vs-Stage4 |
5.343800E-02 |
| Stage2-vs-Stage3 |
8.214400E-01 |
| Stage2-vs-Stage4 |
2.200800E-01 |
| Stage3-vs-Stage4 |
2.732000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57223999999179E-05 |
| Normal-vs-AfricanAmerican |
4.696900E-03 |
| Normal-vs-Asian |
7.997400E-01 |
| Caucasian-vs-AfricanAmerican |
5.128600E-01 |
| Caucasian-vs-Asian |
3.797800E-01 |
| AfricanAmerican-vs-Asian |
4.577200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6321999999902E-05 |
| Normal-vs-Female |
3.022400E-03 |
| Male-vs-Female |
7.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.258800E-01 |
| Normal-vs-Extreme_Weight |
3.425600E-04 |
| Normal-vs-Obese |
6.830200E-04 |
| Normal-vs-Extreme_Obese |
6.179400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.811700E-02 |
| Normal_Weight-vs-Obese |
1.336570E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.922400E-01 |
| Extreme_Weight-vs-Obese |
7.351000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.967800E-01 |
| Obese-vs-Extreme_Obese |
2.866600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.985000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.24699999995526E-06 |
| Normal-vs-Age(61-80Yrs) |
6.591700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.291200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.704600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.493410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.898000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.469990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.437800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.357800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.65234534125148E-12 |
| Normal-VS-Type2 PRCC |
4.144400E-01 |
| Normal-VS-KIRP CIMP |
3.891000E-01 |
| Normal-VS-Unclassified PRCC |
5.518200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.38500322321988E-11 |
| Type1 PRCC-VS-KIRP CIMP |
7.443600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.356900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.004200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.553790E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.185800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.191800E-01 |
| Normal-vs-N1 |
3.748600E-01 |
| Normal-vs-N2 |
2.435700E-02 |
| N0-vs-N1 |
9.030400E-01 |
| N0-vs-N2 |
1.574840E-01 |
| N1-vs-N2 |
1.218810E-01 |
|
|
